Sickle cell disease in California: Sociodemographic predictors of emergency department utilization

Pediatric Blood and Cancer

Volumn 58, Issue 1, 2012, Pages 66-73

  Wolfson, Julie A ^a   Schrager, Sheree M ^b   Khanna, Rachna ^c   Coates, Thomas D ^b,d   Kipke, Michele D ^b,d  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Distance; Emergency department; Sickle cell disease; Utilization

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; COHORT ANALYSIS; DEMOGRAPHY; EMERGENCY WARD; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH INSURANCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SICKLE CELL ANEMIA; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, SICKLE CELL; CALIFORNIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEMOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MIDDLE AGED; PATIENT ADMISSION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 81155133246     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22979     Document Type: Article

References (57)

1. Michlitsch J, Azimi M, Hoppe C, et al. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 2009; 52: 486-490.
2. Ballas SK, Lieff S, Benjamin LJ, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol 2010; 85: 6-13.
3. Orkin SH, Nathan DG, Ginsburg D, et al. editors. Nathan and Oski's Hematology of Infancy and Childhood. Philadelphia: Saunders Elsevier; 2009.
4. Panepinto JA, Brousseau DC, Hillery CA, et al. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer 2005; 44: 182-186.
5. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991; 325: 11-16.
6. Shankar SM, Arbogast PG, Mitchel E, et al. Medical care utilization and mortality in sickle cell disease: A population-based study. Am J Hematol 2005; 80: 262-270.
7. Bilenker JH, Weller WE, Shaffer TJ, et al. The costs of children with sickle cell anemia: Preparing for managed care. J Pediatr Hematol Oncol 1998; 20: 528-533.
8. Epstein K, Yuen E, Riggio JM, et al. Utilization of the office, hospital and emergency department for adult sickle cell patients: A five-year study. J Natl Med Assoc 2006; 98: 1109-1113.
9. Hand R, Koshy M, Dorn L, et al. Health insurance status and the use of emergency and other outpatient services by adults with sickle cell disease. Ann Emerg Med 1995; 25: 224-229.
10. Kauf TL, Coates TD, Huazhi L, et al. The cost of health care for children and adults with sickle cell disease. Am J Hematol 2009; 84: 323-327.
11. Raphael JL, Dietrich CL, Whitmire D, et al. Healthcare utilization and expenditures for low income children with sickle cell disease. Pediatr Blood Cancer 2009; 52: 263-267.
12. Telfair J, Haque A, Etienne M, et al. Rural/urban differences in access to and utilization of services among people in Alabama with sickle cell disease. Public Health Rep 2003; 118: 27-36.
13. Yusuf HR, Atrash HK, Grosse SD, et al. Emergency department visits made by patients with sickle cell disease: A descriptive study, 1999-2007. Am J Prev Med 2010; 38: S536-S541.
14. Hagar RW, Vichinsky EP. Major changes in sickle cell disease. Adv Pediatr 2000; 47: 249-272.
15. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2007; 44: 1428-1433.
16. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment. JAMA 2003; 289: 1645-1651.
17. Vichinsky E, Hurst D, Earles A, et al. Newborn screening for sickle cell disease: Effect on mortality. Pediatrics 1988; 81: 749-755.
18. Quinn CT, Rogers ZR, McCavit TL, et al. Improved survival of children and adolescents with sickle cell disease. Blood 2010; 115: 3447-3452.
19. Medi-Cal Facts: California Children's Services & Medi-Cal. Medi-Cal Policy Institute: A Project of the California HealthCare Foundation; 2000. Report.
20. Nietert PJ, Abboud MR, Zoller JS, et al. Costs, charges, and reimbursements for persons with sickle cell disease. J Pediatr Hematol Oncol 1999; 21: 389-396.
21. Shankar SM, Arbogast PG, Mitchel E, et al. Impact of proximity to comprehensive sickle cell center on utilization of healthcare services among children with sickle cell disease. Pediatr Blood Cancer 2008; 50: 66-71.
22. Davis H, Gergen PJ, Moore RM, Jr. Geographic differences in mortality of young children with sickle cell disease in the United States. Public Health Rep 1997; 112: 52-58.
23. Epstein AM, Ayanian JZ. Racial disparities in medical care. N Engl J Med 2001; 344: 1471-1473.
24. Frei-Jones MJ, Baxter AL, Rogers ZR, et al. Vaso-occlusive episodes in older children with sickle cell disease: Emergency department management and pain assessment. J Pediatr 2008; 152: 281-285.
25. Koshy M, Leikin J, Dorn L, et al. Evaluation and management of sickle cell disease in the emergency department (an 18-year experience): 1974-1992. Am J Ther 1994; 1: 309-320.
26. Loureiro MM, Rozenfeld S, Sa Carvalho M, et al. Factors associated with hospital readmission in sickle cell disease. BMC Blood Disord 2009; 9: 2.
27. Mayer ML, Konrad TR, Dvorak CC. Hospital resource utilization among patients with sickle cell disease. J Health Care Poor Underserved 2003; 14: 122-135.
28. Okpala I, Thomas V, Westerdale N, et al. The comprehensiveness care of sickle cell disease. Eur J Haematol 2002; 68: 157-162.
29. Teach SJ, Lillis KA, Grossi M. Compliance with penicillin prophylaxis in patients with sickle cell disease. Arch Pediatr Adolesc Med 1998; 152: 274-278.
30. Yang YM, Shah AK, Watson M, et al. Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. Public Health Rep 1995; 110: 80-86.
31. Haque A, Telfair J. Socioeconomic distress and health status: The urban-rural dichotomy of services utilization for people with sickle cell disorder in North Carolina. J Rural Health 2000; 16: 43-55.
32. Davis H, Moore RM, Jr., Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep 1997; 112: 40-43.
33. Lanzkron S, Haywood C, Jr., Segal JB, et al. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Am J Hematol 2006; 81: 927-932.
34. Strouse JJ, Jordan LC, Lanzkron S, et al. The excess burden of stroke in hospitalized adults with sickle cell disease. Am J Hematol 2009; 84: 548-552.
35. Woods K, Karrison T, Koshy M, et al. Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Public Health Rep 1997; 112: 44-51.
36. Ellison AM, Bauchner H. Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease. J Natl Med Assoc 2007; 99: 192-196.
37. Machlin S, Cohen J, Elixhauser A, et al. Sensitivity of household reported medical conditions in the medical expenditure panel survey. Med Care 2009; 47: 618-625.
38. Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization project: An overview. Eff Clin Pract 2002; 5: 143-151.
39. Carroll CP, Haywood C, Jr., Fagan P, et al. The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization. Am J Hematol 2009; 84: 666-670.
40. Kuhlthau K, Ferris TG, Beal AC, et al. Who cares for medicaid-enrolled children with chronic conditions? Pediatrics 2001; 108: 906-912.
41. Sox CM, Cooper WO, Koepsell TD, et al. Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. JAMA 2003; 290: 1057-1061.
42. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. Agency for Healthcare Research and Quality, <>. Accessed December, 2009.
43. American Society of Hematology, 2008 September 15. American Society of Hematology: Find a Hematologist. <>. Accessed 2009 September 15.
44. Ponce N. Personal communication, 2009.
45. Brousseau DC, Owens PL, Mosso AL, et al. Acute care utilization and rehospitalizations for sickle cell disease. JAMA 2010; 303: 1288-1294.
46. Brousseau DC, Panepinto JA, Owens P, et al. Acute care visits in sickle cell disease: A population-based multi-state study. ASH Annu Meet Abstr 2008; 112: 165.
47. Zuckerman S, Shen YC. Characteristics of occasional and frequent emergency department users: Do insurance coverage and access to care matter? Med Care 2004; 42: 176-182.
48. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1644.
49. Grosse SD, Schechter MS, Kulkarni R, et al. Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders. Pediatrics 2009; 123: 407-412.
50. Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: An approach for the management of uncomplicated painful crises. Blood 2000; 95: 1130-1136.
51. Raphael JL, Kamdar A, Beavers MB, et al. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital. Pediatr Blood Cancer 2008; 51: 82-85.
52. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med 1997; 127: 666-674.
53. Gorelick MH, Knight S, Alessandrini EA, et al. Lack of agreement in pediatric emergency department discharge diagnoses from clinical and administrative data sources. Acad Emerg Med 2007; 14: 646-652.
54. Kahn LH, Blustein J, Arons RR, et al. The validity of hospital administrative data in monitoring variations in breast cancer surgery. Am J Public Health 1996; 86: 243-245.
55. Rahimy MC, Fanou L, Somasse YE, et al. When to start supplementary iron to prevent iron deficiency in early childhood in sub-Saharan Africa setting. Pediatr Blood Cancer 2007; 48: 544-549.
56. Ryan S, Riley A, Kang M, et al. The effects of regular source of care and health need on medical care use among rural adolescents. Arch Pediatr Adolesc Med 2001; 155: 184-190.
57. National Institutes of Health, The management of sickle cell disease. NIH Publication No. 02-2117. Bethesda, MD: National Heart Lung and Blood Institute; 2002. Report.